5 results on '"Vacchelli, Erika"'
Search Results
2. Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
- Author
-
Galluzzi, Lorenzo, Vitale, Ilio, Senovilla, Laura, Olaussen, Ken André, Pinna, Guillaume, Eisenberg, Tobias, Goubar, Aïcha, Martins, Isabelle, Michels, Judith, Kratassiouk, Gueorgui, Carmona-Gutierrez, Didac, Scoazec, Marie, Vacchelli, Erika, Schlemmer, Frederic, Kepp, Oliver, Shen, Shensi, Tailler, Maximilien, Niso-Santano, Mireia, Morselli, Eugenia, and Criollo, Alfredo
- Subjects
VITAMIN B6 metabolism ,LUNG cancer prognosis ,LUNG cancer treatment ,CISPLATIN ,BIOENERGETICS ,DNA damage - Abstract
Summary: Patients with non-small cell lung cancer (NSCLC) are routinely treated with cytotoxic agents such as cisplatin. Through a genome-wide siRNA-based screen, we identified vitamin B6 metabolism as a central regulator of cisplatin responses in vitro and in vivo. By aggravating a bioenergetic catastrophe that involves the depletion of intracellular glutathione, vitamin B6 exacerbates cisplatin-mediated DNA damage, thus sensitizing a large panel of cancer cell lines to apoptosis. Moreover, vitamin B6 sensitizes cancer cells to apoptosis induction by distinct types of physical and chemical stress, including multiple chemotherapeutics. This effect requires pyridoxal kinase (PDXK), the enzyme that generates the bioactive form of vitamin B6. In line with a general role of vitamin B6 in stress responses, low PDXK expression levels were found to be associated with poor disease outcome in two independent cohorts of patients with NSCLC. These results indicate that PDXK expression levels constitute a biomarker for risk stratification among patients with NSCLC. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
3. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.
- Author
-
Pietrocola, Federico, Pol, Jonathan, Vacchelli, Erika, Rao, Shuan, Enot, David P., Baracco, Elisa E., Levesque, Sarah, Castoldi, Francesca, Jacquelot, Nicolas, Yamazaki, Takahiro, Senovilla, Laura, Marino, Guillermo, Aranda, Fernando, Durand, Sylvère, Sica, Valentina, Chery, Alexis, Lachkar, Sylvie, Sigl, Verena, Bloy, Norma, and Buque, Aitziber
- Subjects
- *
LOW-calorie diet , *ANTINEOPLASTIC agents , *AUTOPHAGY , *T cells , *HYDROXYCITRIC acid , *SPERMIDINE - Abstract
Summary Caloric restriction mimetics (CRMs) mimic the biochemical effects of nutrient deprivation by reducing lysine acetylation of cellular proteins, thus triggering autophagy. Treatment with the CRM hydroxycitrate, an inhibitor of ATP citrate lyase, induced the depletion of regulatory T cells (which dampen anticancer immunity) from autophagy-competent, but not autophagy-deficient, mutant KRAS-induced lung cancers in mice, thereby improving anticancer immunosurveillance and reducing tumor mass. Short-term fasting or treatment with several chemically unrelated autophagy-inducing CRMs, including hydroxycitrate and spermidine, improved the inhibition of tumor growth by chemotherapy in vivo. This effect was only observed for autophagy-competent tumors, depended on the presence of T lymphocytes, and was accompanied by the depletion of regulatory T cells from the tumor bed. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. Crosstalk between ER stress and immunogenic cell death.
- Author
-
Kepp, Oliver, Menger, Laurie, Vacchelli, Erika, Locher, Clara, Adjemian, Sandy, Yamazaki, Takahiro, Martins, Isabelle, Sukkurwala, Abdul Qader, Michaud, Michael, Senovilla, Laura, Galluzzi, Lorenzo, Kroemer, Guido, and Zitvogel, Laurence
- Subjects
- *
ENDOPLASMIC reticulum , *PHYSIOLOGICAL stress , *IMMUNOGENETICS , *CELL death , *IMMUNE response , *ANTHRACYCLINES - Abstract
Abstract: Preclinical and clinical findings suggest that tumor-specific immune responses may be responsible – at least in part – for the clinical success of therapeutic regimens that rely on immunogenic cell death (ICD) inducers, including anthracyclines and oxaliplatin. The molecular pathways whereby some, but not all, cytotoxic agents promote bona fide ICD remain to be fully elucidated. Nevertheless, a central role for the endoplasmic reticulum (ER) stress response has been revealed in all scenarios of ICD described thus far. Hence, components of the ER stress machinery may constitute clinically relevant druggable targets for the induction of ICD. In this review, we will summarize recent findings in the field of ICD research with a special focus on ER stress mechanisms and their implication for cancer therapy. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
5. Mitochondrial gateways to cancer
- Author
-
Galluzzi, Lorenzo, Morselli, Eugenia, Kepp, Oliver, Vitale, Ilio, Rigoni, Alice, Vacchelli, Erika, Michaud, Mickael, Zischka, Hans, Castedo, Maria, and Kroemer, Guido
- Subjects
- *
MITOCHONDRIA , *CELL death , *REACTIVE oxygen species , *BIOENERGETICS , *ADENOSINE triphosphate , *CANCER invasiveness , *EXTRACELLULAR matrix , *ENDOPLASMIC reticulum - Abstract
Abstract: Mitochondria are required for cellular survival, yet can also orchestrate cell death. The peculiar biochemical properties of these organelles, which are intimately linked to their compartmentalized ultrastructure, provide an optimal microenvironment for multiple biosynthetic and bioenergetic pathways. Most intracellular ATP is generated by mitochondrial respiration, which also represents the most relevant source of intracellular reactive oxygen species. Mitochondria participate in a plethora of anabolic pathways, including cholesterol, cardiolipin, heme and nucleotide biosynthesis. Moreover, mitochondria integrate numerous pro-survival and pro-death signals, thereby exerting a decisive control over several biochemical cascades leading to cell death, in particular the intrinsic pathway of apoptosis. Therefore, it is not surprising that cancer cells often manifest the deregulation of one or several mitochondrial functions. The six classical hallmarks of cancer (i.e., limitless replication, self-provision of proliferative stimuli, insensitivity to antiproliferative signals, disabled apoptosis, sustained angiogenesis, invasiveness/metastatic potential), as well as other common features of tumors (i.e., avoidance of the immune response, enhanced anabolic metabolism, disabled autophagy) may directly or indirectly implicate deregulated mitochondria. In this review, we discuss several mechanisms by which mitochondria can contribute to malignant transformation and tumor progression. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.